Contracts › HT942523C0069
HT942523C0069: Dha Sequential Phase Ii Sbir Deployable Wound Care Products to Decrease Preventable Death Outcomes By Mitigating Infection on Battlefield and Through Long Term Care
Awarded to Kericure Inc. by Defense Health Agency.
$1.3Mobligated
$1.3Mpotential value
21 April 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942523C0069 |
|---|---|
| Awardee | Kericure Inc. |
| Awarding agency | Defense Health Agency |
| Awarding office | DEFENSE HEALTH AGENCY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | FL |
| Offers received | 1 |
| Period of performance | 22 September 2023 to 21 April 2027 |
| Potential end | 21 April 2027 |
| Estimated recompete solicitation | ~Q4 2026 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record